CD19+ B cells from IFNα/βR-sufficient mice displayed a significant activation (~70% CD69+) upon TMEV infection compared with the CD19+ B cells (16% CD69+) from IFNα/βR-deficient mice, suggesting the involvement of IFNα/β in B cell activation. The gene discussed is CD19; the disease is infection.